Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Anthrax: HELP
Articles by Dimitrios G. Bouzianas
Based on 3 articles published since 2007
||||

Between 2007 and 2017, Dimitrios G. Bouzianas wrote the following 3 articles about Anthrax.
 
+ Citations + Abstracts
1 Review Current and future medical approaches to combat the anthrax threat. 2010

Bouzianas, Dimitrios G. ·Laboratory of Molecular Endocrinology, Division of Endocrinology and Metabolism, AHEPA University Hospital, 1 S. Kyriakidi Street, P.C. 54636, Thessaloniki, Macedonia, Greece. bouzianas@the.forthnet.gr ·J Med Chem · Pubmed #20102155.

ABSTRACT: -- No abstract --

2 Review Medical countermeasures to protect humans from anthrax bioterrorism. 2009

Bouzianas, Dimitrios G. ·Technological Educational Institute of Thessaloniki, Department of Medical Laboratories, Laboratory of Immunology and Microbiology, PO Box 145-61, Thessaloniki 541-01, Macedonia, Greece. bouzianas@the.forthnet.gr ·Trends Microbiol · Pubmed #19781945.

ABSTRACT: The deliberate dissemination of Bacillus anthracis spores via the US mail system in 2001 confirmed their potential use as a biological weapon for mass human casualties. This dramatically highlighted the need for specific medical countermeasures to enable the authorities to protect individuals from a future bioterrorism attack. Although vaccination appears to be the most effective and economical form of mass protection, current vaccines have significant drawbacks that justify the immense research effort to develop improved treatment modalities. After eight years and an expenditure of more than $50 billion, only marginal progress has been made in developing effective therapeutics. This article summarizes the most important medical countermeasures that have mostly been developed since the 2001 events, and highlights current problems and possible avenues for future research.

3 Review Potential biological targets of Bacillus anthracis in anti-infective approaches against the threat of bioterrorism. 2007

Bouzianas, Dimitrios G. ·Department of Medical Laboratories, Faculty of Health and Care Professions, University-level Technological Educational Institute of Thessaloniki, Greece. dimm@mls.teithe.gr ·Expert Rev Anti Infect Ther · Pubmed #17678429.

ABSTRACT: The terrorist attacks of 2001 involving anthrax underscore the imperative that safe and effective medical countermeasures should be readily available. Vaccination appears to be the most effective form of mass protection against a biological attack, but the current vaccines have drawbacks that justify the enormous amount of effort currently being put into developing more effective vaccines and other treatment modalities. After providing a comprehensive overview of the organism Bacillus anthracis as a biological weapon and its pathogenicity, this review briefly summarizes the current knowledge vital to the management of anthrax disease. This knowledge has been acquired since 2001 as a result of the progress on anthrax research and focuses on the possible development of improved human anti-infective strategies targeting B. anthracis spore components, as well as strategies based on host-pathogen interactions.